Piramal Pharma (PPLPHARMA.NSE) Q1 2026 Earnings

28JanConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.81
-0.14
0.53
1.2

Details

Expected EPS
-0.051197695
Actual EPS
-0.71676773
Surprise EPS
-0.67
Surprise Percent
+1,300%

Description

Piramal Pharma (PPLPHARMA.NSE) has reported earnings of -0.71676773 per share for Q1 2026.

0 Comments

Share your thoughts